When administering anti-infective agents, what infections might you assess for?

When administering anti-infective agents, it is essential to assess for superinfections. A superinfection occurs when a patient develops a new infection while undergoing treatment for an existing infection, particularly with antibiotics. This can happen because anti-infective agents may disrupt the normal flora, leading to an overgrowth of opportunistic pathogens that weren't previously problematic. For instance, the use of broad-spectrum antibiotics can result in Clostridium difficile infection or yeast infections due to an imbalance in the microbiome.

Monitoring for superinfections is crucial because these infections can complicate treatment, require additional medications, and prolong the patient's recovery. By being vigilant in assessing for superinfections, healthcare providers can respond promptly, ensuring that patients receive appropriate care and minimizing the risk of further complications from both the original infection and any new ones that may arise.

In contrast, the other conditions listed—cardiovascular diseases, autoimmune disorders, and chronic respiratory conditions—are not directly related to the assessment during the administration of anti-infective agents. While these conditions may influence the overall health of the patient and how they respond to treatment, they are not specific infections that need to be assessed for when using anti-infectives.